Clinical Trials Arena February 3, 2025
Ross Law

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial success.

This year’s Outsourcing in Clinical Trials (OCT): Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of matters including clinical trial planning, design, and execution, the importance of good data, and meeting compliance requirements for regulation, from the European Union’s artificial intelligence Act (EU AI Act) to achieving CE mark certification.

AI was a frequent theme on the agenda. The conference featured some compelling insights into the technology’s development and applicability towards helping to evolve patient care, along with several use cases of the technology in supporting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Medical Devices, Technology
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
Medical device cyber updates must consider patient safety
Open Source Healthcare – The Cure for Stagnant Medical Innovation
Stryker to sell US spinal implants business to investment firm

Share This Article